We are writing to urge you to cosponsor our bipartisan legislation, H.R. 2905, the Medicare IVIG Access Enhancement Act. The bill would provide much-needed assistance to Medicare patients suffering from two rare diseases, Chronic Inflammatory Demyelinating
Polyneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN). These debilitating conditions are the result of a patient’s own immune system attacking their motor nerves, leading to compromised mobility and reduced quality of life. Patients are frequently treated
with intravenous immune globulin (IVIG), a plasma-derived medicine that can significantly improve health outcomes for these vulnerable patient populations.